{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:48:08Z","timestamp":1787316488891,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1,15]]},"DOI":"10.1097\/tp.0b013e318277e344","type":"journal-article","created":{"date-parts":[[2012,12,7]],"date-time":"2012-12-07T07:14:32Z","timestamp":1354864472000},"page":"240-246","source":"Crossref","is-referenced-by-count":105,"title":["Characteristics of Early and Late PTLD Development in Pediatric Solid Organ Transplant Recipients"],"prefix":"10.1097","volume":"95","author":[{"given":"Tilmann","family":"Schober","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodor","family":"Framke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Kreipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Grohennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kais","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Margret","family":"Wingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Maecker-Kolhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-35-20210129","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1345\/aph.1G706","article-title":". Posttransplant lymphoproliferative disorder.","volume":"41","author":"Everly","year":"2007","journal-title":"Ann Pharmacother"},{"key":"R2-35-20210129","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1399-3046.2008.00969.x","article-title":". Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.","volume":"13","author":"Schubert","year":"2009","journal-title":"Pediatr Transplant"},{"key":"R3-35-20210129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2141.2010.08161.x","article-title":". Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipientsBCSH and BTS guidelines.","volume":"149","author":"Parker","year":"2010","journal-title":"Br J Haematol"},{"key":"R4-35-20210129","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1111\/j.1600-6143.2012.04206.x","article-title":". Low-dose chemotherapy and rituximab for posttransplant lymphoproliferative disease (PTLD): a Childrens Oncology Group report.","volume":"12","author":"Gross","year":"2012","journal-title":"Am J Transplant"},{"key":"R5-35-20210129","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2009.25.4961","article-title":". Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.","volume":"28","author":"Evens","year":"2010","journal-title":"J Clin Oncol"},{"key":"R6-35-20210129","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(06)67933-6","article-title":". Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study.","volume":"367","author":"Webber","year":"2006","journal-title":"Lancet"},{"key":"R7-35-20210129","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1200\/JCO.2006.10.2392","article-title":". CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.","volume":"25","author":"Maecker","year":"2007","journal-title":"J Clin Oncol"},{"key":"R8-35-20210129","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1470-2045(11)70300-X","article-title":". Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.","volume":"13","author":"Trappe","year":"2012","journal-title":"Lancet Oncol"},{"key":"R9-35-20210129","first-page":"2052","article-title":"Charlotte F, et al..","volume":"16","author":"Leblond","year":"1998","journal-title":"Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity J Clin Oncol"},{"key":"R10-35-20210129","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1600-6143.2011.03896.x","article-title":". Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas.","volume":"12","author":"Caillard","year":"2012","journal-title":"Am J Transplant"},{"key":"R11-35-20210129","first-page":"244","article-title":"Macon WR, et al..","volume":"79","author":"Ghobrial","year":"2005","journal-title":"Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases Transplantation"},{"key":"R12-35-20210129","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S1053-2498(01)00314-X","article-title":". Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases.","volume":"20","author":"Paranjothi","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"R13-35-20210129","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.21911","article-title":". Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States.","volume":"86","author":"Quinlan","year":"2011","journal-title":"Am J Hematol"},{"key":"R14-35-20210129","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.TP.0000146385.40108.2B","article-title":". Simultaneous development of lymphoma in recipients of renal transplants from a single donor: donor origin confirmed by human leukocyte antigen staining and microsatellite analysis.","volume":"79","author":"Caillard","year":"2005","journal-title":"Transplantation"},{"key":"R15-35-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report.","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"R16-35-20210129","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1034\/j.1399-3046.2002.1r058.x","article-title":"Long-term outcome after liver transplantation in children.","volume":"6","author":"Bucuvalas","year":"2002","journal-title":"Pediatr Transplant"},{"key":"R17-35-20210129","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":". Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression.","volume":"80","author":"Caillard","year":"2005","journal-title":"Transplantation"},{"key":"R18-35-20210129","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.healun.2010.10.004","article-title":". Role of immunosuppression regimen in post-transplant lymphoproliferative disorder in pediatric heart transplant patients.","volume":"30","author":"Dayton","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R19-35-20210129","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.healun.2010.01.013","article-title":". Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.","volume":"29","author":"Manlhiot","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R20-35-20210129","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.healun.2007.09.027","article-title":". Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.","volume":"27","author":"Schubert","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R21-35-20210129","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.TP.0000085602.22498.CF","article-title":"Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se T","volume":"76","author":"Birkeland","year":"2003","journal-title":"ransplantation"},{"key":"R22-35-20210129","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/01.TP.0000079832.00991.EE","article-title":". Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.","volume":"76","author":"Gulley","year":"2003","journal-title":"Transplantation"},{"key":"R23-35-20210129","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/path.2555","article-title":". Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.","volume":"218","author":"Capello","year":"2009","journal-title":"J Pathol"},{"key":"R24-35-20210129","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1600-6143.2011.03544.x","article-title":". Post-transplant lymphoproliferative disorders: determination of donorrecipient origin in a large cohort of kidney recipients.","volume":"11","author":"Olagne","year":"2011","journal-title":"Am J Transplant"},{"key":"R25-35-20210129","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1600-6143.2011.03968.x","article-title":". CXCL13 as a novel marker for diagnosis and disease monitoring in pediatric PTLD.","volume":"12","author":"Schiffer","year":"2012","journal-title":"Am J Transplant"},{"key":"R26-35-20210129","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1111\/j.1600-6143.2006.01540.x","article-title":". Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French registry.","volume":"6","author":"Caillard","year":"2006","journal-title":"Am J Transplant"},{"key":"R27-35-20210129","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1600-6143.2005.00776.x","article-title":". Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience.","volume":"5","author":"Trofe","year":"2005","journal-title":"Am J Transplant"},{"key":"R28-35-20210129","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":". Toxicity and response criteria of the Eastern Cooperative Oncology Group.","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"R29-35-20210129","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.1989.7.2.186","article-title":". Non-Hodgkins lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution.","volume":"7","author":"Murphy","year":"1989","journal-title":"J Clin Oncol"},{"key":"R30-35-20210129","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":". A predictive model for aggressive non-Hodgkins lymphoma. The International Non-Hodgkins Lymphoma Prognostic Factors Project.","volume":"329","author":"Shipp","year":"1993","journal-title":"N Engl J Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-201301150-00035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T21:48:19Z","timestamp":1618264099000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201301150-00035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,15]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318277e344","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,15]]}}}